Lung cancer incidence and survival among HIV-infected and uninfected women and men

AIDS

Volumn 29, Issue 10, 2015, Pages 1183-1193

  Hessol, Nancy A ^a   Martínez Maza, Otoniel ^b   Levine, Alexandra M ^c   Morris, Alison ^d   Margolick, Joseph B ^e   Cohen, Mardge H ^f   Jacobson, Lisa P ^e   Seaberg, Eric C ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f RUSH UNIVERSITY   (United States)

Author keywords

AIDS; HIV infection; Incidence; Lung cancer; Survival

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SMOKING; UNITED STATES; ADVERSE EFFECTS; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RISK ASSESSMENT; SURVIVAL ANALYSIS;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK ASSESSMENT; SMOKING; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84942935982     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000690     Document Type: Article

References (48)

1. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645-1654.
2. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123:187-194.
3. Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006; 24:1383-1388.
4. Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA. Elevated risk of lung cancer among people with AIDS. AIDS 2007; 21:207-213.
5. Shiels MS, Cole SR, Mehta SH, Kirk GD. Lung cancer incidence andmortalityamong HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr 2010; 55:510-515.
6. Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis 2010; 51:957-962.
7. Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010; 153:452-460.
8. Crothers K, Huang L, Goulet JL, Goetz MB, Brown S, Rodriguez-Barradas M, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011; 183:388-395.
9. Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis 2003; 37:292-298.
10. Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc 2011; 8:313-319.
11. Cadranel J, Garfield D, Lavole A, Wislez M, Milleron B, Mayaud C. Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 2006; 61:1000-1008.
12. Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, et al. HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol 2010; 28:1514-1519.
13. Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 2012; 106:447-452.
14. Hessol NA, Weber KM, D'Souza G, Burton D, Young M, Milam J, et al. Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study. Am J Prev Med 2014; 47:53-69.
15. Kirk GD, Merlo C, O' Driscoll P, Mehta SH, Galai N, Vlahov D, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007; 45:103-110.
16. Ruiz M. Lung cancer in HIV-infected patients: the experience of an urban clinic. J Int Assoc Physicians AIDS Care (Chic) 2010; 9:214-217.
17. Bearz A, Vaccher E, Martellotta F, Spina M, Talamini R, Lleshi A, et al. Lung cancer in HIV positive patients: the GICAT experience. Eur Rev Med Pharmacol Sci 2014; 18:500-508.
18. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-Analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52:611-622.
19. Seaberg EC, Wiley D, Martinez-Maza O, Chmiel JS, Kingsley L, Tang Y, et al. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 2010; 116:5507-5516.
20. Dubrow R, Silverberg MJ, Park LS, Crothers K, Justice AC. HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol 2012; 24:506-516.
21. Shcherba M, Shuter J, Haigentz M Jr. Current questions in HIV-Associated lung cancer. Curr Opin Oncol 2013; 25:511-517.
22. Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011; 20:2551-2559.
23. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-Analysis. Lancet 2007; 370:59-67.
24. Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009; 10:1152-1159.
25. Kesselring A, Gras L, Smit C, van Twillert G, Verbon A, de Wolf F, et al. Immunodeficiency as a risk factor for non-AIDSdefining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis 2011; 52:1458-1465.
26. Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST, et al. HIV as an independent risk factor for incident lung cancer. AIDS 2012; 26:1017-1025.
27. Lavole A, Wislez M, Antoine M, Mayaud C, Milleron B, Cadranel J. Lung cancer, a new challenge in the HIV-infected population. Lung Cancer 2006; 51:1-11.
28. Palacios R, Pascual J, Cabrera E, Lebron JM, Guerrero-Leon MA, del Arco A, et al. Lung cancer in HIV-infected patients. Int J STD AIDS 2014; 25:239-243.
29. Shebl FM, Engels EA, Goedert JJ, Chaturvedi AK. Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr 2010; 55:375-379.
30. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005; 12:1013-1019.
31. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-125.
32. Kaslow R, Ostrow D, Detels R, Phair J. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-318.
33. Hofferkamp J. Standards for Cancer Registries Volume III: standards for completeness, quality, analysis, management, security and confidentiality of data. Springfield, Illinois: North American Association of Central Cancer Registries; 2008.
34. DHHS. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; 2004.
35. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
36. SAS Institute Inc. SAS/STAT User's Guide, Version 9.3. Cary, North Carolina: SAS Institute Inc.; 2010.
37. StataCorp. Stata Statistical Software: Release 12. College Station, Texas: StataCorp LP; 2011.
38. Cytel Software Corporation. StatXact 10.0. Cambridge, Massachusetts: Cytel Software Corporation; 2012.
39. Robbins HA, Shiels MS, Pfeiffer RM, Engels EA. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS 2014; 28:881-890.
40. Morris A, George MP, Crothers K, Huang L, Lucht L, Kessinger C, et al. HIV and chronic obstructive pulmonary disease: is it worse and why? Proc Am Thorac Soc 2011; 8:320-325.
41. Bobba RK, Holly JS, Loy T, PerryMC. Scar carcinoma of the lung: a historical perspective. Clin Lung Cancer 2011; 12:148-154.
42. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007; 165:1143-1153.
43. Hakimian R, Fang H, Thomas L, Edelman MJ. Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2007; 2:268-272.
44. Lavole A, Chouaid C, Baudrin L, Wislez M, Raguin G, Pialoux G, et al. Effect of highly active antiretroviral therapy on survival of HIV infected patients with nonsmall-cell lung cancer. Lung Cancer 2009; 65:345-350.
45. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ. Treating tobacco use and dependence: 2008 Update. US Department of Health and Human Services; 2008.
46. Ebbert JO, Sood A, Hays JT, Dale LC, Hurt RD. Treating tobacco dependence: review of the best and latest treatment options. J Thorac Oncol 2007; 2:249-256.
47. Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 2007; 56:125-134.
48. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003; 18:156-170.